D. Harlan

D. Harlan, M. Atkinson, David M. Blodgett, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Effects of Exenatide Alone and in Combination With Daclizumab on β-Cell Function in Long-Standing Type 1 Diabetes

D. Harlan, L. Spain, K. Rother, 2009, Diabetes Care.

Sirolimus-induced interstitial pneumonitis in an islet transplant recipient.

D. Harlan, K. Rother, B. Hirshberg, 2003, Diabetes care.

Dynamic Changes in Pancreatic Endocrine Cell Abundance, Distribution, and Function in Antigen-Induced and Spontaneous Autoimmune Diabetes

D. Harlan, O. Gavrilova, K. Koczwara, 2009, Diabetes.

Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations

S. Libutti, D. Harlan, W. Linehan, 2009, PloS one.

Islet-infiltrating t lymphocytes in insulin-dependent diabetic patients express CD80 (B7-1) and CD86 (B7-2).

D. Harlan, Y. Matsuzawa, A. Imagawa, 1996, Journal of autoimmunity.

Dependent Mice Is T Cell Autoantigen-Specific and Rat Insulin Promoter-mCD 80-Transgenic Low Dose Streptozotocin-Induced Diabetes in

D. Harlan, B. Boehm, C. Blum, 2001 .

Low Dose Streptozotocin-Induced Diabetes in Rat Insulin Promoter-mCD80-Transgenic Mice Is T Cell Autoantigen-Specific and CD28 Dependent1 2

D. Harlan, B. Boehm, C. Blum, 2001, The Journal of Immunology.

Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6.

D. Harlan, A. Kirk, P. Blair, 2001, Transplantation.

State of the Art: Islet Transplantation for the Cure of Type 1 Diabetes Mellitus

D. Harlan, K. Rother, B. Hirshberg, 2003, Reviews in Endocrine and Metabolic Disorders.

Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.

J. Gaglia, D. Harlan, K. Rother, 2003, Diabetes care.

Resistin is expressed in pancreatic islets.

D. Harlan, O. Gavrilova, C. Vinson, 2003, Biochemical and biophysical research communications.

Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes

D. Harlan, R. Maehr, C. Mathews, 2016, Nature Medicine.

Blood Glucose Levels Regulate Pancreatic β-Cell Proliferation during Experimentally-Induced and Spontaneous Autoimmune Diabetes in Mice

D. Harlan, K. Koczwara, Victor S. Harrison, 2009, PloS one.

Islet transplantation as a treatment for diabetes.

D. Harlan, K. Rother, 2004, The New England journal of medicine.

Efficacy and Toxicity of a Protocol Using Sirolimus, Tacrolimus and Daclizumab in a Nonhuman Primate Renal Allotransplant Model

D. Harlan, A. Kirk, He Xu, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.

H. Noushmehr, D. Harlan, S. Li Calzi, 2003, Endocrinology.

Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD–scid IL-2rgnull RIP-DTR mice engrafted with human islets

D. Harlan, P. Herrera, D. Greiner, 2015, Diabetes, metabolic syndrome and obesity : targets and therapy.

Effect of Ingested Interferon-α on β-Cell Function in Children With New-Onset Type 1 Diabetes

D. Harlan, K. Rother, Rebecca J. Brown, 2009, Diabetes Care.

How much insulin is enough? A quantitative assessment of the transdifferentiaton potential of liver

D. Harlan, S. Perl, J. Tisdale, 2007, Diabetologia.

Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

D. Harlan, A. Kirk, C. Ricordi, 1999, Proceedings of the National Academy of Sciences of the United States of America.

A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: possible role of membrane TNF.

D. Harlan, P. Vassalli, P. Herrera, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Humanized mice for the study of type 1 and type 2 diabetes

D. Harlan, A. Powers, D. Greiner, 2011, Annals of the New York Academy of Sciences.

Primate skin allotransplantation with anti-CD154 monotherapy.

D. Harlan, A. Kirk, E. Elster, 2001, Transplantation proceedings.

Very-Low-Dose Streptozotocin Induces Diabetes in Insulin Promoter-mB7-1 Transgenic Mice

D. Harlan, C. June, G. Gray, 1995, Diabetes.

Current Advances and Travails in Islet Transplantation

D. Harlan, N. Kenyon, O. Korsgren, 2009, Diabetes.

The role of CD154 in organ transplant rejection and acceptance.

D. Harlan, A. Kirk, P. Blair, 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Model of Skin Allotransplantation Antibody IDEC-131 in a Nonhuman Primate Rapamycin , and the CD 154-Specific Donor-Specific Blood Transfusion , Studies Investigating Pretransplant

Tadaki, D. Allan, D. Harlan, 2003 .

Promise of costimulatory pathway modifying reagents for transplantation

D. Harlan, A. Kirk, 2000 .

Challenges for the clinical application of transplant tolerance strategies

D. Harlan, A. Kirk, 2000 .

Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model.

D. Harlan, A. Kirk, E. Elster, 2001, Transplantation proceedings.

Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.

D. Harlan, A. Kirk, E. Elster, 2001, Transplantation.

Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow.

D. Harlan, C. Civin, J. Chute, 2002, Blood.

A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes

D. Harlan, W. Hagopian, B. Bisikirska, 2005, Diabetes.

Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes

D. Harlan, A. Remaley, K. Rother, 2017, Diabetes Care.

Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670

D. Harlan, M. Quon, K. Rother, 2014, Diabetes Care.

Comment on: Keenan et al. (2010) Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study. Diabetes 2010;59:2846–2853

D. Harlan, K. Rother, 2010, Diabetes.

RABBIT ANTITHYMOCYTE GLOBULIN INDUCTION AND SIROLIMUS MONOTHERAPY SUPPORTS PROLONGED ISLET ALLOGRAFT FUNCTION IN A NONHUMAN PRIMATE ISLET TRANSPLANTATION MODEL

D. Harlan, A. Kirk, He Xu, 2003, Transplantation.

Immunologic monitoring of the transplant recipient: challenges and approaches with antibody induction

D. Harlan, A. Kirk, D. Kleiner, 2003 .

Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness.

D. Harlan, H. Pircher, G. Freeman, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Protection against lethal toxic shock by targeted disruption of the CD28 gene

D. Harlan, C. June, K. Lee, 1996, The Journal of experimental medicine.

Inflammatory cytokines IFN-gamma plus TNF-alpha induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts.

D. Harlan, C. June, K. Lee, 1997, Journal of immunology.

Islet Cell Transplantation

D. Harlan, E. Liu, 2008 .

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: Response to Charles and Selam

D. Harlan, K. Rother, B. Hirshberg, 2004 .

Adult Human Pancreatic Islet Beta-Cells Display Limited Turnover and Long Lifespan as Determined by In-Vivo Thymidine Analog Incorporation and Radiocarbon Dating

D. Harlan, J. Kushner, B. Buchholz, 2010 .

Rapid Publication L o n g - Term Survival and Function of Intrahepatic Islet Allografts in Baboons Treated With Humanized Anti-CD154

D. Harlan, G. Iaria, A. Kirk, 1999 .

Cd40 Ligand (Cd154) Triggers a Short-Term Cd4+ T Cell Activation Response That Results in Secretion of Immunomodulatory Cytokines and Apoptosis

D. Harlan, A. Kirk, P. Blair, 2000, The Journal of experimental medicine.

The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection?

D. Harlan, A. Kirk, 1999, JAMA.

Preincubation with endothelial cell monolayers increases gene transfer efficiency into human bone marrow CD34(+)CD38(-) progenitor cells.

D. Harlan, P. Blair, J. Chute, 2000, Human gene therapy.

Transitional Blood Flow Zones between Ischemic and Nonischemic Myocardium in the Awake Dog: Analysis Based on Distribution of the Intramural Vasculature

D. Harlan, F. Cobb, J. J. Morris, 1983, Circulation research.

Transduction of rat pancreatic islets with pseudotyped adeno-associated virus vectors

D. Harlan, J. Chiorini, O. Gavrilova, 2009, Virology Journal.

Response to Comment on Harlan. Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor. Diabetes Care 2016;39:1072–1074

D. Harlan, 2017, Diabetes Care.

Preclinical evaluation of tolerance induction protocols and islet transplantation in non‐human primates

D. Harlan, A. Kirk, D. Hale, 2001, Immunological reviews.

Cell Differentiation from a Human Cell Line Pathways in CD34+ Progenitor to Dendritic Evidence for Distinct Intracellular Signaling

D. Harlan, P. Blair, C. June, 2013 .

Corrigendum: Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes

D. Harlan, R. Maehr, C. Mathews, 2017, Nature Medicine.

Extrapancreatic Autoantibody Profiles in Type I Diabetes

D. Harlan, M. Rewers, M. Iadarola, 2012, PloS one.

Evidence for Distinct Intracellular Signaling Pathways in CD34+ Progenitor to Dendritic Cell Differentiation from a Human Cell Line Model

D. Harlan, P. Blair, C. June, 1999, The Journal of Immunology.

A factor in food which impairs Na+-K+-ATPase in vitro.

D. Harlan, G. Mann, 1982, The American journal of clinical nutrition.

Beta cell-specific CD80 (B7-1) expression disrupts tissue protection from autoantigen-specific CTL-mediated diabetes.

D. Harlan, B. Boehm, C. Blum, 2003, Journal of autoimmunity.

Current Opinion in Endocrinology, Diabetes and Obesity: Editorial introductions

D. Harlan, Annabelle Rodriguez, 2011 .

Survival After Pancreas Transplantation—Reply

D. Harlan, M. McBride, 2005 .

INDUCTION THERAPY WITH MONOCLONAL ANTIBODIES SPECIFIC FOR CD80 AND CD86 DELAYS THE ONSET OF ACUTE RENAL ALLOGRAFT REJECTION IN NON-HUMAN PRIMATES1

D. Harlan, A. Kirk, E. Elster, 2001, Transplantation.

Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation

D. Harlan, A. Kirk, E. Elster, 2002, Transplantation.

Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site.

J. Gaglia, D. Harlan, A. Kirk, 2002, Diabetes.

Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression.

D. Harlan, B. Hirshberg, N. Patterson, 2002, The Journal of clinical endocrinology and metabolism.

Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates.

D. Harlan, A. Kirk, E. Elster, 2002, Transplantation.

Inducing unresponsiveness by the use of anti-CD3 immunotoxin, CTLA4-Ig, and anti-CD40 ligand.

D. Harlan, A. Kirk, Y. Dong, 1999, Transplantation proceedings.

HLA Class II Antigen Processing and Presentation Pathway Components Demonstrated by Transcriptome and Protein Analyses of Islet β-Cells From Donors With Type 1 Diabetes

D. Harlan, M. Garber, N. Morgan, 2019, Diabetes.

Susceptibility or resistance to Leishmania infection is dictated by the macrophages evolved under the influence of IL‐3 or GM‐CSF

D. Harlan, P. Perrin, T. Davis, 1999, European journal of immunology.

A CD8+ T-lymphocyte-mediated and CD4+ T-lymphocyte-independent autoimmune diabetes of early onset in transgenic mice

L. Orci, D. Harlan, J. Vassalli, 1994, Diabetologia.

Long‐Term Immunosuppression After Solitary Islet Transplantation Is Associated With Preserved C‐Peptide Secretion for More Than a Decade

D. Harlan, K. Rother, W. Flegel, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effects of Combined Treatment with CD25‐ and CD154‐Specific Monoclonal Antibodies in Non‐Human Primate Allotransplantation

D. Harlan, A. Kirk, E. Elster, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Human platelets activate porcine endothelial cells through a CD154-dependent pathway.

D. Harlan, F. Arnaud, A. Kirk, 2001, Transplantation.

Immune intervention with anti-CD3 in diabetes

D. Harlan, M. Herrath, 2005, Nature Medicine.

Ethnicity Greatly Influences Cytokine Gene Polymorphism Distribution

D. Harlan, A. Kirk, P. Blair, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Model Cell Differentiation from a Human Cell Line Progenitor to Dendritic + Pathways in CD 34 Evidence for Distinct Intracellular Signaling

D. Harlan, P. Blair, C. June, 1999 .

Phorbol esters induce differentiation of human CD34+ hemopoietic progenitors to dendritic cells: evidence for protein kinase C-mediated signaling.

D. Harlan, P. Blair, B. Levine, 1998, Journal of immunology.

Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes

A. Paterson, A. Riggs, D. Harlan, 2014, Diabetes.

α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes

Diane C. Saunders, D. Harlan, S. Levy, 2018, Cell reports.

Low dose poly I:C prevents diabetes in the diabetes prone BB rat.

D. Harlan, A. Bagg, D. Sobel, 1998, Journal of autoimmunity.

alpha Cell Function and Gene Expression Are Compromised in Type 1 Diabetes

Diane C. Saunders, D. Harlan, S. Levy, 2019 .

Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4+ T Cells in Patients With Type 1 Diabetes

D. Harlan, A. Powers, R. Bottino, 2018, Diabetes.

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.

D. Harlan, W. Hagopian, J. Bluestone, 2002, The New England journal of medicine.

The MAFB transcription factor impacts islet α-cell function in rodents and represents a unique signature of primate islet β-cells.

D. Harlan, R. Stein, L. Goodrich, 2016, American journal of physiology. Endocrinology and metabolism.

Immunological Concerns with Bioengineering Approaches

D. Harlan, D. Metzger, D. Munn, 2002, Annals of the New York Academy of Sciences.

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

D. Harlan, A. Kirk, J. Fechner, 1999, Nature Medicine.

End Sequence Analysis ToolKit ( ESAT ) expands the extractable from single cell RNA-seq experiments

Maxim N. Artyomov, Allon M. Klein, D. Harlan, 2016 .

Assessment of Human Pancreatic Islet Architecture and Composition by Laser Scanning Confocal Microscopy

Alvin C. Powers, Marcela Brissova, D. Harlan, 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Peak stimulated insulin secretion is associated with specific changes in gene expression profiles in sporadic insulinomas.

S. Libutti, D. Harlan, P. Gorden, 2003, Surgery.

Disruption of CD40/CD40-Ligand Interactions in a Retinal Autoimmunity Model Results in Protection without Tolerance

D. Harlan, S. Hoffmann, R. Kampen, 2005, The Journal of Immunology.

Tolerance Model Results in Protection without Interactions in a Retinal Autoimmunity Disruption of CD 40 / CD 40-Ligand

D. Harlan, S. Hoffmann, R. Kampen, 2005 .

Cytotoxic T Cell–Mediated Diabetes in RIP‐CD80 Transgenic Mice

D. Harlan, S. Chakrabarty, K. Pechhold, 2007, Annals of the New York Academy of Sciences.

Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion.

D. Harlan, C. June, K. Lee, 1995, Clinical immunology and immunopathology.

Cells: Evidence for Protein Kinase C-Mediated Hemopoietic Progenitors to Dendritic + CD34Esters Induce Differentiation of Human

D. Harlan, P. Blair, C. June, 2017 .

Phorbol Esters Induce Differentiation of Human

D. Harlan, C. June, T. Davis, 1998 .

The pancreatic &bgr;-cell transcriptome and integrated-omics

D. Harlan, David M. Blodgett, A. Cura, 2014, Current opinion in endocrinology, diabetes, and obesity.

Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates

Robert Langer, Siddharth Jhunjhunwala, Jie Li, 2016, Nature Biotechnology.

Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation

D. Harlan, E. Wang, D. Stroncek, 2007, Journal of Translational Medicine.

T cell–directed therapies: lessons learned and future prospects

D. Harlan, J. O’Shea, R. Siegel, 2007, Nature Immunology.

Oligonucleotide Microarray Analysis of Intact Human Pancreatic Islets: Identification of Glucose-Responsive Genes and a Highly Regulated TGFβ Signaling Pathway

D. Harlan, J. Brady, C. Pise-Masison, 2002 .

Studies Investigating Pretransplant Donor-Specific Blood Transfusion, Rapamycin, and the CD154-Specific Antibody IDEC-131 in a Nonhuman Primate Model of Skin Allotransplantation1

D. Harlan, A. Kirk, He Xu, 2003, The Journal of Immunology.

Infant formula, autoimmune triggers, and type 1 diabetes.

D. Harlan, Mary M. Lee, 2010, The New England journal of medicine.

Differences in the Management of Type 1 Diabetes Among Adults Under Excellent Control Compared With Those Under Poor Control in the T1D Exchange Clinic Registry

D. Harlan, J. McGill, R. Beck, 2013, Diabetes Care.

Decreased pancreatic acinar cell number in type 1 diabetes

Diane C. Saunders, D. Harlan, C. Dai, 2020, Diabetologia.

Assessment of Pancreatic Islet Mass after Islet Transplantation Using In Vivo Bioluminescence Imaging

D. Harlan, E. Jansen, A. Powers, 2005, Transplantation.

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial

Bruce A Buckingham, Darrell M Wilson, M Sue Kirkman, 2017, The Lancet.

Consensus Reports

Lee C. Rogers, William H. Herman, Kirkman, 2011, Diabetes Care.

BRIEF HISTORY OF THE UNITED STATES NAVY TISSUE BANK AND TRANSPLANTATION PROGRAMME.: CAPTAIN KENNETH SELL'S LIVING LEGACY

D. Harlan, P. Blair, T. Contreras, 1998 .

Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes

D. Harlan, M. Quon, K. Rother, 2014, Diabetes Care.

State of Behavioral Health Integration in U.S. Diabetes Care: How Close Are We to ADA Recommendations?

D. Harlan, K. L. MacGregor, Nicole Johnson, 2018, Diabetes Care.

Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.

D. Harlan, K. Rother, 2004, The Journal of clinical investigation.

Recovery of viable endocrine‐specific cells and transcriptomes from human pancreatic islet‐engrafted mice

D. Harlan, M. Garber, S. Redick, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

3-6-2018 α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes

Rita, Diane C. Saunders, D. Harlan, 2018 .

Pancreatic Islet Transplantation

D. Harlan, David M Harlan, Mark A Naftanel, 2004, PLoS medicine.

Effect of indomethacin on coronary vascular response to increased myocardial oxygen consumption.

D. Harlan, T. Rooke, H. Sparks, 1978, The American journal of physiology.

Transcriptional analysis of intracytoplasmically stained, FACS-purified cells by high-throughput, quantitative nuclease protection

D. Harlan, R. Stein, R. Martel, 2009, Nature Biotechnology.

Toxic shock syndrome toxin-1-induced death is prevented by CTLA4Ig.

D. Harlan, C. June, G. Gray, 1996, Journal of immunology.

Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells

D. Harlan, D. Melton, D. Greiner, 2020, Cell Reports.

Islet transplantation: where do we stand now?

D. Harlan, B. Hirshberg, Kristin Rother, 2003, Diabetes/metabolism research and reviews.

Resistin serum levels in type 1 diabetes pre- and post-islet transplantation.

D. Harlan, K. Rother, A. Shalev, 2004, Metabolism: clinical and experimental.

Reply to Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

D. Harlan, A. Kirk, 2000, Nature Medicine.

Survival after pancreas transplantation. Authors' reply

D. Harlan, D. Sutherland, R. Gruessner, 2005 .

Gene-altered islets for transplant: giant leap or small step?

D. Harlan, 2004, Endocrinology.

Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor

D. Harlan, 2016, Diabetes Care.

Increased insulin translation from an insulin splice-variant overexpressed in diabetes, obesity, and insulin resistance.

D. Harlan, H. Lan, A. Attie, 2005, Molecular endocrinology.

Surprising Heterogeneity of Pancreatic Islet Cell Subsets.

D. Harlan, S. Redick, David M. Blodgett, 2016, Cell systems.

Metabolic Function of a Suboptimal Transplanted Islet Mass in Nonhuman Primates on Rapamycin Monotherapy

D. Harlan, M. Rickels, A. Remaley, 2012, Cell transplantation.

Evaluation of a Diabetes Remote Monitoring Program Facilitated by Connected Glucose Meters for Patients With Poorly Controlled Type 2 Diabetes: Randomized Crossover Trial

S. Lemon, D. McManus, D. Harlan, 2021, JMIR Diabetes.

A proinsulin gene splice variant with increased translation efficiency is expressed in human pancreatic islets.

D. Harlan, P. Blair, B. Peculis, 2002, Endocrinology.

The Clinical Center’s Blood Glucose Management Service

D. Harlan, E. Cochran, R. Malek, 2012, The Diabetes educator.

The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge.

Yen-Ming Hsu, Allan D Kirk, D. Harlan, 2004, International immunology.

Costimulatory molecules are active in the human xenoreactive T-cell response but not in natural killer-mediated cytotoxicity.

D. Harlan, A. Kirk, K. Lee, 2000, Transplantation.

Islet Cell Allotransplantation as a Model System for a Bioengineering Approach to Reparative Medicine

D. Harlan, 2002, Annals of the New York Academy of Sciences.

CD28 co-receptor signal transduction in T-cell activation.

P J Blair, J L Riley, R G Carroll, 1997, Biochemical Society transactions.

Counterpoint: Clinical Islet Transplantation: Not Ready for Prime Time

D. Harlan, Mahfuzul H. Khan, 2009, Diabetes Care.

Pancreatic Islet Transplantation

D. Harlan, M. Naftanel, 2004, PLoS Medicine.

IMPROVING AFTER-HOURS CALLS TO ENDOCRINOLOGY FELLOWS.

D. Harlan, N. Aronin, S. Yeasmin, 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Rescue of hematopoietic stem cells following high-dose radiation injury using ex vivo culture on endothelial monolayers.

D. Harlan, J. Chute, A. Saini, 2002, Military Medicine.

Transforming Growth Factor-/ Smad 3 Signaling Regulates Insulin Gene Transcription and Pancreatic Islet-Cell Function *

D. Harlan, A. Roberts, Seong-Jin Kim, 2009 .

Transforming Growth Factor-β/Smad3 Signaling Regulates Insulin Gene Transcription and Pancreatic Islet β-Cell Function*

D. Harlan, A. Roberts, Seong-Jin Kim, 2009, Journal of Biological Chemistry.

The MAFB transcription factor impacts islet α-cell function in rodents and represents a unique signature of primate islet β-cells.

D. Harlan, R. Stein, L. Goodrich, 2016, American journal of physiology. Endocrinology and metabolism.

Possible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR model

D. Harlan, D. Greiner, N. Walsh, 2017, PloS one.

mRNA analysis of intracytoplasmically-stained, FACS-purified pancreatic islet cells using the quantitative nuclease protection assay

D. Harlan, R. Stein, R. Martel, 2009, Nature Biotechnology.

The Clinical Center’s Blood Glucose Management Service

D. Harlan, E. Cochran, R. Malek, 2012, The Diabetes educator.